Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validity and Reliability Evaluation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Adult-type Diffuse Gliomas Patients in Chinese Population

NCT05486923 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT05486923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05486923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validity and Reliability Evaluation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) for Adult-type Diffuse Gliomas Patients in Chinese Population
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Completed
Start date
September 19, 2022
Completion date
February 1, 2025
Enrollment
450 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

adverse effects, glioma, patient reported outcome measures, self report